These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1113305)
21. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia. Medoff G; Valeriote F; Lynch RG; Schlessinger D; Kobayashi GS Cancer Res; 1974 May; 34(5):974-8. PubMed ID: 4823906 [No Abstract] [Full Text] [Related]
22. Suppression of antibody-mediated and cell-mediated murine immunity by the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide. Headley DB; Cohen SM; Bryan GT Cancer Res; 1977 Apr; 37(4):974-9. PubMed ID: 14783 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma. Gomi K; Morimoto M; Nomoto K Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702 [TBL] [Abstract][Full Text] [Related]
24. The effect of anti-lymphocyte and anti-thymocyte serum on the pathogenesis of Rauscher leukaemia in inbred mouse strains. Váczi L; Leövey A; Tóth FD; Kása M Acta Microbiol Acad Sci Hung; 1976; 23(4):309-16. PubMed ID: 1088332 [TBL] [Abstract][Full Text] [Related]
25. Lymphocyte surface receptors and leukemia virus-induced immunosuppression. Friedman H; Kateley JR Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386 [TBL] [Abstract][Full Text] [Related]
26. Detection of lymphoid leukemia colony-forming cells in Abelson virus infected mice: differences in inbred strains. Earl CD; Scher CD J Cell Physiol; 1980 Aug; 104(2):153-62. PubMed ID: 7410487 [TBL] [Abstract][Full Text] [Related]
27. Cell-mediated anti-tumor response in the RLmale 1 system. I. T nature, H-2Dd involvement and antigenic specificity of the effector cells. Duprez V; Gomard E; Levy JP Eur J Immunol; 1978 Sep; 8(9):650-5. PubMed ID: 81780 [No Abstract] [Full Text] [Related]
28. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity. Chesebro B; Wehrly K J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583 [TBL] [Abstract][Full Text] [Related]
29. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction. Ruddle NH; Armstrong MY; Richards FF J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884 [No Abstract] [Full Text] [Related]
30. [Experimental model for the study of antitumor immunity combined action drugs]. Fioretti MC; Bonmassar E G Ital Chemioter; 1979; 26(1-2):357-62. PubMed ID: 554824 [No Abstract] [Full Text] [Related]
31. Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency. Medoff G; Valeriote F; Ryan J; Tolen S J Natl Cancer Inst; 1977 Apr; 58(4):949-53. PubMed ID: 845998 [TBL] [Abstract][Full Text] [Related]
32. Drug-mediated immunogenic changes of virus-induced leukemia in vivo. Houchens DP; Bonmassar E; Gaston MR; Kende M; Goldin A Cancer Res; 1976 Apr; 36(4):1347-52. PubMed ID: 1260759 [TBL] [Abstract][Full Text] [Related]
33. BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution. Muirhead MJ; Isakson PC; Krolick KA; Uhr JW; Vitetta ES Am J Pathol; 1981 Dec; 105(3):295-305. PubMed ID: 7032308 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of a tumor allograft in BALB/c x DBA/2 F1 mice by pyran copolymer. Mohr SJ; Chirigos MA; Fuhrman F; Smith G Cancer Res; 1976 Apr; 36(4):1315-9. PubMed ID: 1260757 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex. Lu L; Shen RN; Zhou SZ; Srivastava C; Harrington M; Miyazawa K; Wu B; Lin ZH; Ruscetti S; Broxmeyer HE Int J Hematol; 1991 Apr; 54(2):117-24. PubMed ID: 1660735 [TBL] [Abstract][Full Text] [Related]
36. Evolution of acute lymphoblastic leukemia in mice treated with carrier-bound methotrexate and levamisole. Soriano L; Rivera-Fillat MP; Grau-Oliete MR Chemotherapy; 1987; 33(2):123-8. PubMed ID: 3471392 [TBL] [Abstract][Full Text] [Related]
37. Levamisole inactive in treatment of four animal tumours. Potter CW; Carr I; Jennings R; Rees RC; McGinty F; Richardson VM Nature; 1974 Jun; 249(457):567-9. PubMed ID: 4834081 [No Abstract] [Full Text] [Related]
38. Role of levamisole as immunomodulant in mouse lymphoma model. Turriziani M; Giuliani A; Bulgarini B; De Vecchis L Immunopharmacol Immunotoxicol; 1991; 13(3):425-45. PubMed ID: 1940057 [TBL] [Abstract][Full Text] [Related]
39. Increased life-span in AKR leukemia mice treated with prophylactic chemotherapy. Straus MJ; Choi SC; Goldin A Cancer Res; 1973 Jul; 33(7):1724-8. PubMed ID: 4721231 [No Abstract] [Full Text] [Related]
40. Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response. Yu CS; Lai KC; Yang JS; Chiang JH; Lu CC; Wu CL; Lin JP; Liao CL; Tang NY; Wood WG; Chung JG Phytother Res; 2010 Feb; 24(2):163-8. PubMed ID: 19449452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]